Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignant Germ Cell Tumor”

646 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 646 results

Very early researchLooking for participantsNCT05773326
What this trial is testing

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Who this might be right for
High Grade GliomaGliomaGlioma, Malignant+1 more
Nader Sanai 12
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT00453310
What this trial is testing

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTeratoma+1 more
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableUnknownNCT01637753
What this trial is testing

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+1 more
Shandong Lanjin Pharmaceuticals Co.,Ltd 212
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00002558
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 108
Testing effectiveness (Phase 2)Ended earlyNCT00014443
What this trial is testing

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Rush University Medical Center 5
Early research (Phase 1)Study completedNCT00613223
What this trial is testing

Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas

Who this might be right for
GliosarcomaGlioblastoma
Annick Desjardins 49
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT00283556
What this trial is testing

High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

Who this might be right for
Malignant Glioma
Kentuckiana Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT00076986
What this trial is testing

The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
INSYS Therapeutics Inc 300
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00025675
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Testing effectiveness (Phase 2)Study completedNCT00467051
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

Who this might be right for
Childhood Extracranial Germ Cell TumorChildhood Extragonadal Malignant Germ Cell TumorChildhood Malignant Ovarian Germ Cell Tumor+13 more
Children's Oncology Group 20
Early research (Phase 1)Ended earlyNCT01494012
What this trial is testing

Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorMalignant Tumor of Peritoneum+2 more
Stanford University 1
Testing effectiveness (Phase 2)Study completedNCT00038441
What this trial is testing

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Who this might be right for
GliomaBrain Neoplasms
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00957905
What this trial is testing

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Who this might be right for
Recurrent Extragonadal SeminomaRecurrent Malignant Extragonadal Germ Cell TumorRecurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor+6 more
National Cancer Institute (NCI) 36
Load More Results